EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)ÄquivalenzstudieMultizentrische Studie

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism

Isabelle Mahé iD, Marc Carrier iD, Didier Mayeur, Jean Chidiac, Eric Vicaut, Nicolas Falvo, Olivier Sanchez, Claire Grange, Manuel Monreal, Juan J López-Núñez iD, Remedios Otero-Candelera, Grégoire Le Gal und 24 weitere

New England Journal of Medicine · 10.04.2025 · 392 (14) · 1363-1373

DOI: 10.1056/nejmoa2416112 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 10.04.2025. Verfasst von Isabelle Mahé und 35 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Service de Médecine Interne, Colombes, France. Hauptthemen laut MEDLINE: Factor Xa Inhibitors, Hemorrhage, Neoplasms, Pulmonary Embolism. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Bristol-Myers Squibb–Pfizer Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor Xa InhibitorsHemorrhageNeoplasmsPulmonary EmbolismVenous ThrombosisAgedFemaleHumansMaleMiddle AgedAdministration, OralDouble-Blind MethodDrug Administration SchedulePyrazolesPyridonesRecurrenceDose-Response Relationship, DrugIncidence

Substanzen

apixabanFactor Xa InhibitorsPyrazolesPyridones

Autor:innen und Institutionen

  • Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Service de Médecine Interne, Colombes, France.
  • Université Paris Cité, Paris.
  • INSERM Unité Mixte de Recherche S970, Paris Cardiovascular Research Center, Team "Endotheliopathy and Hemostasis Disorders," Paris.
  • Investigation Network on Venous Thrombo-Embolism-French Clinical Research Infrastructure Network, Saint-Étienne, France.
  • Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa.
  • Centre Georges-François Leclerc, Dijon, France.

ORCID-Profile: Isabelle Mahé, Marc Carrier, Juan J López-Núñez, Menno V Huisman, Frederikus A Klok, Laurent Bertoletti

Förderung

  • Bristol-Myers Squibb–Pfizer Alliance

Zitieren

APA

Mahé, I., Carrier, M., Mayeur, D., Chidiac, J., Vicaut, E., Falvo, N., Sanchez, O., Grange, C., Monreal, M., López-Núñez, J. J., Otero-Candelera, R., Le Gal, G., Yeo, E., Righini, M., Robert-Ebadi, H., Huisman, M. V., Klok, F. A., Westerweel, P., Agnelli, G., …, & API-CAT Investigators (2025). Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism. New England Journal of Medicine, 392(14), 1363-1373. https://doi.org/10.1056/nejmoa2416112

Vancouver

Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, et al. Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism. New England Journal of Medicine. 2025;392(14):1363-1373. doi:10.1056/nejmoa2416112

BibTeX
@article{Mah2025,
  author = {Mahé, Isabelle and Carrier, Marc and Mayeur, Didier and Chidiac, Jean and Vicaut, Eric and Falvo, Nicolas and Sanchez, Olivier and Grange, Claire and Monreal, Manuel and López-Núñez, Juan J and Otero-Candelera, Remedios and Le Gal, Grégoire and Yeo, Erik and Righini, Marc and Robert-Ebadi, Helia and Huisman, Menno V and Klok, Frederikus A and Westerweel, Peter and Agnelli, Giancarlo and Becattini, Cecilia and Bamias, Aristotelis and Syrigos, Kostas and Szmit, Sebastian and Torbicki, Adam and Verhamme, Peter and Maraveyas, Anthony and Cohen, Alexander T and Ay, Cihan and Chapelle, Céline and Meyer, Guy and Couturaud, Francis and Mismetti, Patrick and Girard, Philippe and Bertoletti, Laurent and Laporte, Silvy and API-CAT Investigators, API-CAT Investigators},
  title = {Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {14},
  pages = {1363--1373},
  doi = {10.1056/nejmoa2416112}
}
Kostenlos starten →